{"title":"Recurrence of piriformis syndrome: One year follow up post ultrasound guided injection therapy","authors":"Yusak Mangara Tua Siahaan, V. Sungono, P. Tiffani","doi":"10.37897/rjn.2023.1.8","DOIUrl":null,"url":null,"abstract":"Background. Piriformis syndrome is a common cause of low back pain sometimes underdiagnosed due to a lack of distinguishing symptoms and patterns. Two methods of ultrasound-guided intramuscular injection (using a local anesthetic agent and combined with corticosteroids) have become the treatments of choice. However, some studies suggest these methods may result in recurrence even though data regarding the prevalence of recurrence and triggering factors are still lacking. Objective. To identify the prevalence of and factors triggering the recurrence of piriformis syndrome treated with steroid and local anesthetic injections. Methods. This is a prospective cohort following patients diagnosed with piriformis syndrome and treated with either a local anesthetic or a combination with the addition of corticosteroids. Demographic, risk factors, and the onset of pain recurrence data were taken and analyzed. Results. From the 66 patients included in this study, 68.2% (n:45) reported recurrence of pain, with the majority occurring within the first three months post-injection. Subjects treated with combination therapy had a pain-free interval 13.45 weeks longer than subjects treated with a local anesthetic injection. There were no significant differences in risk factors between both groups. Conclusion. Recurrence of piriformis syndrome was most commonly found within the first and third months of treatment. Both methods did not differ significantly, even though combination therapy tends to give longer pain-relief intervals.","PeriodicalId":37662,"journal":{"name":"Romanian Journal of Neurology/ Revista Romana de Neurologie","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Romanian Journal of Neurology/ Revista Romana de Neurologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37897/rjn.2023.1.8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background. Piriformis syndrome is a common cause of low back pain sometimes underdiagnosed due to a lack of distinguishing symptoms and patterns. Two methods of ultrasound-guided intramuscular injection (using a local anesthetic agent and combined with corticosteroids) have become the treatments of choice. However, some studies suggest these methods may result in recurrence even though data regarding the prevalence of recurrence and triggering factors are still lacking. Objective. To identify the prevalence of and factors triggering the recurrence of piriformis syndrome treated with steroid and local anesthetic injections. Methods. This is a prospective cohort following patients diagnosed with piriformis syndrome and treated with either a local anesthetic or a combination with the addition of corticosteroids. Demographic, risk factors, and the onset of pain recurrence data were taken and analyzed. Results. From the 66 patients included in this study, 68.2% (n:45) reported recurrence of pain, with the majority occurring within the first three months post-injection. Subjects treated with combination therapy had a pain-free interval 13.45 weeks longer than subjects treated with a local anesthetic injection. There were no significant differences in risk factors between both groups. Conclusion. Recurrence of piriformis syndrome was most commonly found within the first and third months of treatment. Both methods did not differ significantly, even though combination therapy tends to give longer pain-relief intervals.
期刊介绍:
ROMANIAN JOURNAL OF NEUROLOGY (Revista Română de Neurologie), the official journal of the Romanian Society of Neurology, was founded in 2001, being a prestigious scientific journal that provides a high quality in terms of scientific content, but also the editorial and graphic aspect, both through an impartial process of selection, evaluation and correction of articles (peer review procedure), as well as providing editorial, graphic and printing conditions at the highest level. In order to increase the scientific standards of the journal, special attention was paid to the improvement of the quality of the published materials. Guidance articles, clinical trials and case studies are structured in several sections: reviews, original articles, case reports, images in neurology. All articles are published entirely in English. A team of reputable medical professionals in the field of neurology is involved in a rigorous peer review process that complies with international ethics and quality rules in the academic world.